Clinical Trials in Guangdong, Guangdong
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Alveolar Soft Part Sarcoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.33 enrolled15 locationsNCT07548177
Recruiting
Phase 1
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.216 enrolled19 locationsNCT07043751
Recruiting
Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Crohn's DiseaseUlcerative Colitis
Takeda183 enrolled16 locationsNCT06764615
Recruiting
Not Applicable
Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia
ITP - Immune Thrombocytopenia
Guangzhou Bio-gene Technology Co., Ltd40 enrolled1 locationNCT06813157
Recruiting
An Evaluation of the KCCQ Score in Predicting Cardiovascular Risk in Dialysis Patients
Heart FailureChronic Kidney Disease Stage 5Dialysis
Shenzhen Second People's Hospital136 enrolled1 locationNCT06542016
Recruiting
Early Phase 1
Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL
Therapy Related Leukemia
Zhujiang Hospital100 enrolled1 locationNCT03407859